Can Skin Allograft Occasionally Act as a Permanent Coverage in Deep Burns? A Pilot Study.
Autor: | Rezaei E; Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Beiraghi-Toosi A; Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Ahmadabadi A; Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Tavousi SH; Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Alipour Tabrizi A; Iranian Legal Medicine Research Center, Legal Medicine Organization, Tehran, Iran., Fotuhi K; Department of Surgery, Imam Khomeini Hospital, Northern Khorasan University of Medical Sciences, Shirvan, Iran., Jabbari Nooghabi M; Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Manafi A; Shahid Beheshti University of Medical Sciences, Tehran, Iran., Ahmadi Moghadam S; School of Medicine, Islamic Azad University, Tehran Branch, Tehran, Iran. |
---|---|
Jazyk: | angličtina |
Zdroj: | World journal of plastic surgery [World J Plast Surg] 2017 Jan; Vol. 6 (1), pp. 94-99. |
Abstrakt: | Background: Skin allograft is the gold standard of wound coverage in patients with extensive burns; however, it is considered as a temporary wound coverage and rejection of the skin allograft is considered inevitable. In our study, skin allograft as a permanent coverage in deep burns is evaluated. Methods: Skin allograft survival was assessed in 38 patients from March 2009 to March 2014, retrospectively. Because of the lack of tissue specimen from the skin donors, patients with long skin allograft survival in whom the gender of donor and recipient of allograft was the same were excluded. Seven cases with skin allograft longevity and opposite gender in donor and recipient were finally enrolled. A polymerase chain reaction (PCR) test on the biopsy specimen from recipients and donors were undertaken. Results: PCR on the biopsy specimen from recipients confirmed those specimens belong to the donors. All patients received allograft from the opposite sex. Two (28.57%) patients received allograft from their first-degree blood relatives, and in one (14.29%) case, the allograft was harvested from an alive individual with no blood relation. The rest were harvested from multiorgan donors. In eight months of follow up, no clinical evidence of graft rejection was noted. Conclusion: Long term persistence of skin allograft in patients is worthy of more attention. Further studies An increase in knowledge of factors influencing this longevity could realize the dream of burn surgeons to achieve a permanent coverage other than autograft for major burn patients. |
Databáze: | MEDLINE |
Externí odkaz: |